Breaking News

Breaking news filtered in real-time to show only the most impactful headlines for US-listed public companies.

Pennant Announces Home Health Acquisition in Wyoming

(NASDAQ:PNTG) EAGLE, Idaho, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and se...

Will the acquisition increase Pennant's geographic diversification enough to mitigate risk and attract new institutional investors? What synergies and cost savings does Pennant expect from the Wyoming expansion, and how quickly can they be realized? How will the acquisition of Healing Hearts Home Health and Healing Hearts Outpatient Therapy affect Pennant's earnings guidance and valuation multiples?
Symbol: PNTG
Mergers
5 days ago
Read more globenewswire

Faraday Future Founder and Co-CEO YT Jia Makes Second Stock Purchase Under 10b5-1 Plan, Underscoring Confidence in the Company’s Long-Term Strategy

(NASDAQ:FFAI) LOS ANGELES, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intel...

What does this level of insider buying indicate about Faraday Future’s upcoming strategic initiatives or financing needs compared to past patterns? How might the scheduled insider purchases next week affect short‑term liquidity and trading volume for FFAI? Will YT Jia’s ongoing purchases under the 10b5‑1 plan boost investor confidence and drive the FFAI stock higher?
Symbol: FFAI
Insider
5 days ago
Read more globenewswire

Lithia & Driveway (LAD) Announces Upsizing And Pricing Of Senior Notes Offering

(NYSE:LAD) MEDFORD, Ore., Sept. 3, 2025 /PRNewswire/ -- Lithia & Driveway (NYSE: LAD) today announced the pricing of $600 million in aggregate principal amount of its 5.500% senior notes due 2030 (...

What are the potential implications of this private debt offering for the company's growth initiatives and future equity returns? How does the 5.5% yield on the 2030 notes compare to market rates for comparable issuances in the automotive retail sector? What effect will the $100 million increase in senior notes have on Lithia & Driveway's leverage and credit metrics?
Symbol: LAD
Debt offering
5 days ago
Read more prnewswire

Salesforce issues weak revenue guidance even as earnings beat estimates

(NYSE:CRM) Salesforce reported better-than-expected earnings and revenue for the latest quarter but issued disappointing guidance.

What underlying factors contributed to the disappointing guidance and what are the long‑term implications for growth? How does Salesforce's current guidance compare to analysts' consensus and to its main competitors? What is the expected impact of Salesforce's weak revenue guidance on its stock price?
Symbol: CRM
Earnings
5 days ago
Read more cnbc_tech

Upwork Announces an Additional $100 Million Share Repurchase Program

(NASDAQ:UPWK) Third $100M share repurchase authorization announced since November 2023 Third $100M share repurchase authorization announced since November 2023

How does Upwork’s buyback strategy compare to recent buyback activity among peer platforms and what does it signal about management’s confidence in future growth? What is the company’s current cash position and financing capacity to support three $100 million repurchase programs within a short timeframe? How will the additional $100 million buyback affect UPWK's earnings per share and valuation multiples?
Symbol: UPWK
Buybacks
5 days ago
Read more globenewswire

Replimune (REPL) Faces Investor Lawsuit After FDA Blocks Cancer Drug Approval - Hagens Berman

(NASDAQ:REPL) SAN FRANCISCO, Sept. 3, 2025 /PRNewswire/ -- Replimune Group Inc. (NASDAQ: REPL) is under fire from investors following a dramatic regulatory setback that sent its stock into freefall...

Will this regulatory setback impact REPL's pipeline timelines and its ability to raise capital or partner with larger pharma companies? What are the potential financial liabilities or settlement costs associated with the securities class action? How will the lawsuit and FDA rejection affect REPL's short‑term share price and volatility?
Symbol: REPL
Lawsuits
5 days ago
Read more prnewswire